NOVEL CYCLIC BORONATE INHIBITORS OF HCV REPLICATION

Compounds of formula (I) or a salt thereof are provided; wherein R1, R2, R3, R4, R6, R8, R20, R30, Y, Z and n are as defined in the description. Uses of the compounds as medicaments, and in the manufacture of medicaments for treating viral infection, especially HCV infection are also disclosed. The...

Full description

Saved in:
Bibliographic Details
Main Authors LIAO, LIANG, WHITE, GEMMA VICTORIA, FAN, DAZHONG, ZHANG, YONG KANG, LI, QUN, LI, XIANFENG, SLATER, MARTIN JOHN, NI, ZHI-JIE, QIAN, XUELEI, LAZARIDES, LINOS, PLATTNER, JACOB, JARVEST, RICHARD LEWIS, MORDAUNT, JACQUELINE ELIZABETH, LIU, YANG
Format Patent
LanguageEnglish
French
Published 09.04.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of formula (I) or a salt thereof are provided; wherein R1, R2, R3, R4, R6, R8, R20, R30, Y, Z and n are as defined in the description. Uses of the compounds as medicaments, and in the manufacture of medicaments for treating viral infection, especially HCV infection are also disclosed. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof. L'invention concerne des composés de formule (I) ou un sel de ceux-ci ; dans laquelle R1, R2, R3, R4, R6, R8, R20, R30, Y, Z et n sont tels que définis dans la description. Des utilisations des composés comme médicaments, et dans la fabrication de médicaments pour le traitement d'une infection virale, en particulier une infection par le virus de l'hépatite C sont également décrites. L'invention comprend en outre des procédés de préparation de ces composés et formulations pharmaceutiques de ceux-ci.
Bibliography:Application Number: WO2008US78439